Literature DB >> 17446041

Differential localization of the GluR1 and GluR2 subunits of the AMPA-type glutamate receptor among striatal neuron types in rats.

Y P Deng1, J P Xie, H B Wang, W L Lei, Q Chen, A Reiner.   

Abstract

Differences among the various striatal projection neuron and interneuron types in cortical input, function, and vulnerability to degenerative insults may be related to differences among them in AMPA-type glutamate receptor abundance and subunit configuration. We therefore used immunolabeling to assess the frequency and abundance of GluR1 and GluR2, the most common AMPA subunits in striatum, in the main striatal neuron types. All neurons projecting to the external pallidum (GPe), internal pallidum (GPi) or substantia nigra, as identified by retrograde labeling, possessed perikaryal GluR2, while GluR1 was more common in striato-GPe than striato-GPi perikarya. The frequency and intensity of immunostaining indicated the rank order of their perikaryal GluR1:GluR2 ratio to be striato-GPe>striatonigral>striato-GPi. Ultrastructural studies suggested a differential localization of GluR1 and GluR2 to striatal projection neuron dendritic spines as well, with GluR1 seemingly more common in striato-GPe spines and GluR2 more common in striato-GPi and/or striatonigral spines. Comparisons among projection neurons and interneurons revealed GluR1 to be most common and abundant in parvalbuminergic interneurons, and GluR2 most common and abundant in projection neurons, with the rank order for the GluR1:GluR2 ratio being parvalbuminergic interneurons>calretinergic interneurons>cholinergic interneurons>projection neurons>somatostatinergic interneurons. Striosomal projection neurons had a higher GluR1:GluR2 ratio than did matrix projection neurons. The abundance of both GluR1 and GluR2 in striatal parvalbuminergic interneurons and projection neurons is consistent with their prominent cortical input and susceptibility to excitotoxic insult, while differences in GluR1:GluR2 ratio among projection neurons are likely to yield differences in Ca(2+) permeability, desensitization, and single channel current, which may contribute to differences among them in plasticity, synaptic integration, and excitotoxic vulnerability. The apparent association of the GluR1 subunit with synaptic plasticity, in particular, suggests striato-GPe neuron spines as a particular site of corticostriatal synaptic plasticity, presumably associated with motor learning.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17446041      PMCID: PMC1993922          DOI: 10.1016/j.jchemneu.2007.02.008

Source DB:  PubMed          Journal:  J Chem Neuroanat        ISSN: 0891-0618            Impact factor:   3.052


  146 in total

1.  Ca(2+)-permeable AMPA receptors and selective vulnerability of motor neurons.

Authors:  L Van Den Bosch; W Vandenberghe; H Klaassen; E Van Houtte; W Robberecht
Journal:  J Neurol Sci       Date:  2000-11-01       Impact factor: 3.181

2.  Somatostatin release by glutamate in vivo is primarily regulated by AMPA receptors.

Authors:  G J Hathway; P P Humphrey; K M Kendrick
Journal:  Br J Pharmacol       Date:  2001-11       Impact factor: 8.739

3.  Identification of the source of the bilateral projection system from cortex to somatosensory neostriatum and an exploration of its physiological actions.

Authors:  A K Wright; S Ramanathan; G W Arbuthnott
Journal:  Neuroscience       Date:  2001       Impact factor: 3.590

4.  High abundance of GluR1 mRNA and reduced Q/R editing of GluR2 mRNA in individual NADPH-diaphorase neurons.

Authors:  D Y Kim; S H Kim; H B Choi; C Min ; B J Gwag
Journal:  Mol Cell Neurosci       Date:  2001-06       Impact factor: 4.314

5.  The influence of glutamate receptor 2 expression on excitotoxicity in Glur2 null mutant mice.

Authors:  K Iihara; D T Joo; J Henderson; R Sattler; F A Taverna; S Lourensen; B A Orser; J C Roder; M Tymianski
Journal:  J Neurosci       Date:  2001-04-01       Impact factor: 6.167

6.  Monoclonal antibodies recognizing epitopes of calretinins: dependence on Ca2+-binding status and differences in antigen accessibility in colon cancer cells.

Authors:  L Zimmermann; B Schwaller
Journal:  Cell Calcium       Date:  2002-01       Impact factor: 6.817

7.  Quantitative comparison of anti-fading mounting media for confocal laser scanning microscopy.

Authors:  M Ono; T Murakami; A Kudo; M Isshiki; H Sawada; A Segawa
Journal:  J Histochem Cytochem       Date:  2001-03       Impact factor: 2.479

Review 8.  Pathway tracing using biotinylated dextran amines.

Authors:  A Reiner; C L Veenman; L Medina; Y Jiao; N Del Mar; M G Honig
Journal:  J Neurosci Methods       Date:  2000-11-15       Impact factor: 2.390

Review 9.  Chemical anatomy of striatal interneurons in normal individuals and in patients with Huntington's disease.

Authors:  F Cicchetti; L Prensa; Y Wu; A Parent
Journal:  Brain Res Brain Res Rev       Date:  2000-11

10.  Transient global ischemia in rats yields striatal projection neuron and interneuron loss resembling that in Huntington's disease.

Authors:  C A Meade; G Figueredo-Cardenas; F Fusco; T S Nowak; W A Pulsinelli; A Reiner
Journal:  Exp Neurol       Date:  2000-12       Impact factor: 5.330

View more
  22 in total

1.  Selective inhibition of striatal fast-spiking interneurons causes dyskinesias.

Authors:  Aryn H Gittis; Daniel K Leventhal; Benjamin A Fensterheim; Jeffrey R Pettibone; Joshua D Berke; Anatol C Kreitzer
Journal:  J Neurosci       Date:  2011-11-02       Impact factor: 6.167

Review 2.  Cholinergic interneurons in the dorsal and ventral striatum: anatomical and functional considerations in normal and diseased conditions.

Authors:  Kalynda K Gonzales; Yoland Smith
Journal:  Ann N Y Acad Sci       Date:  2015-04-15       Impact factor: 5.691

3.  Inflammation alters AMPA-stimulated calcium responses in dorsal striatal D2 but not D1 spiny projection neurons.

Authors:  Carissa D Winland; Nora Welsh; Alberto Sepulveda-Rodriguez; Stefano Vicini; Kathleen A Maguire-Zeiss
Journal:  Eur J Neurosci       Date:  2017-10-10       Impact factor: 3.386

4.  Immunohistochemical localization of AMPA-type glutamate receptor subunits in the striatum of rhesus monkey.

Authors:  Yun-Ping Deng; Evan Shelby; Anton J Reiner
Journal:  Brain Res       Date:  2010-05-09       Impact factor: 3.252

5.  Disinhibition of neurons of the nucleus of solitary tract that project to the superior salivatory nucleus causes choroidal vasodilation: Implications for mechanisms underlying choroidal baroregulation.

Authors:  Chunyan Li; Malinda E C Fitzgerald; Nobel Del Mar; Anton Reiner
Journal:  Neurosci Lett       Date:  2016-09-20       Impact factor: 3.046

6.  Confocal laser scanning microscopy and ultrastructural study of VGLUT2 thalamic input to striatal projection neurons in rats.

Authors:  Wanlong Lei; Yunping Deng; Bingbing Liu; Shuhua Mu; Natalie M Guley; Ting Wong; Anton Reiner
Journal:  J Comp Neurol       Date:  2013-04-15       Impact factor: 3.215

7.  Loss of corticostriatal and thalamostriatal synaptic terminals precedes striatal projection neuron pathology in heterozygous Q140 Huntington's disease mice.

Authors:  Y P Deng; T Wong; C Bricker-Anthony; B Deng; A Reiner
Journal:  Neurobiol Dis       Date:  2013-08-19       Impact factor: 5.996

8.  Differential role of N-methyl-D-aspartate receptor subunits 2A and 2B in mediating phencyclidine-induced perinatal neuronal apoptosis and behavioral deficits.

Authors:  N C Anastasio; Y Xia; Z R O'Connor; K M Johnson
Journal:  Neuroscience       Date:  2009-08-03       Impact factor: 3.590

9.  AMPA receptor-dependent H2O2 generation in striatal medium spiny neurons but not dopamine axons: one source of a retrograde signal that can inhibit dopamine release.

Authors:  Marat V Avshalumov; Jyoti C Patel; Margaret E Rice
Journal:  J Neurophysiol       Date:  2008-07-16       Impact factor: 2.714

10.  A kinetic model of dopamine- and calcium-dependent striatal synaptic plasticity.

Authors:  Takashi Nakano; Tomokazu Doi; Junichiro Yoshimoto; Kenji Doya
Journal:  PLoS Comput Biol       Date:  2010-02-12       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.